NCT02273219 2023-08-15
Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Columbia University
Phase 1 Completed
Clinical Trials
7 trialsNCT00885196 2020-12-22
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Novartis
Phase 2 Completed
NCT01402440 2020-12-19
Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
Novartis
Phase 1 Terminated
NCT01430416 2020-12-19
Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Novartis
Phase 1 Completed
NCT01854606 2020-12-19
COEB071X2103
Novartis
Phase 1 Completed
NCT01801358 2020-09-16
A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Array BioPharma
Phase 1/2 Terminated
NCT02285244 2017-04-05
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn